The imperative of reducing contrast dose in percutaneous coronary intervention

JACC: Cardiovascular Interventions

Volumn 7, Issue 11, 2014, Pages 1294-1296

  Mavromatis, Kreton ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic kidney disease; Contrast nephropathy; Percutaneous coronary intervention

Indexed keywords

CONTRAST MEDIUM; IODOBENZOIC ACID DERIVATIVE; IOHEXOL;

CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; DRUG DOSE REDUCTION; DRUG ELUTING STENT; HIGH RISK PATIENT; HUMAN; INTRAVASCULAR CATHETER; INTRAVASCULAR ULTRASOUND; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ANALOGS AND DERIVATIVES; ANGIOCARDIOGRAPHY; DIAGNOSTIC USE; ENDOSCOPIC ECHOGRAPHY; FEMALE; MALE; PROCEDURES;

CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; IOHEXOL; MALE; PERCUTANEOUS CORONARY INTERVENTION; TRIIODOBENZOIC ACIDS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84922518707     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2014.06.011     Document Type: Editorial

References (21)

1. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 2011;58:e44-122.
2. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrastinduced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-9.
3. Marenzi G, Assanelli E, Campodonico J, et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrastinduced nephropathy and mortality. Ann Intern Med 2009;150:170-7.
4. Tan N, Liu Y, Chen JY, et al. Use of the contrast volume or grams of iodine-to-creatinine clearance ratio to predict mortality after percutaneous coronary intervention. Am Heart J 2013; 165:600-8.
5. Mariani J Jr, Guedes C, Soares P, et al. Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. J Am Coll Cardiol Intv 2014;7:1287-93.
6. Nayak KR, Mehta HS, Price MJ, et al. A novel technique for ultra-low contrast administration during angiography or intervention. Catheter Cardiovasc Interv 2010;75:1076-83.
7. Jang JS, Song YJ, Kang W, et al. Intravascular ultrasound-guided implantation of drug-eluting stents to improve outcome: a meta-analysis. J Am Coll Cardiol Intv 2014;7:233-43.
8. Tunuguntla A, Daneault B, Kirtane AJ. Novel use of the GuideLiner catheter to minimize contrast use during PCI in a patient with chronic kidney disease. Catheter Cardiovasc Interv 2012; 80:453-5.
9. Grech M, Debono J, Xuereb RG, Fenech A, Grech V. A comparison between dual axis rotational coronary angiography and conventional coronary angiography. Catheter Cardiovasc Interv 2012;80:576-80.
10. Minsinger KD, Kassis HM, Block CA, Sidhu M, Brown JR. Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrastinduced nephropathy. Am J Cardiol 2014;113: 49-53.
11. Gurm HS, Smith D, Share D, et al. Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol Intv 2013;6: 399-405.
12. Kaye DM, Stub D, Mak V, Doan T, Duffy SJ. Reducing iodinated contrast volume by manipulating injection pressure during coronary angiography. Catheter Cardiovasc Interv 2014;83:741-5.
13. Duffy SJ, Ruygrok P, Juergens CP, et al. Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention. J Am Coll Cardiol 2010; 56:525-6.
14. Freeman RV, O?Donnell M, Share D, et al., for the Blue Cross-Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002;90:1068-73.
15. Laskey WK, Jenkins C, Selzer F, et al., for the NHLBI Dynamic Registry Investigators. Volumeto-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol 2007;50:584-90.
16. Nyman U, Björk J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 2008;49:658-67.
17. Brown JR, Robb JF, Block CA, et al. Does safe dosing of iodinated contrast prevent contrastinduced acute kidney injury? Circ Cardiovasc Interv 2010;3:346-50.
18. Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv 2011;78: 198-201.
19. Gurm HS, Dixon SR, Smith DE, et al., for the BMC2 Registry. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2011;58:907-14.
20. Liu Y, Tan N, Zhou YL, He PC, Luo JF, Chen JY. The contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy after primary percutaneous coronary intervention. Int Urol Nephrol 2012;44:221-9.
21. Kooiman J, Seth M, Share D, Dixon S, Gurm HS. The association between contrast dose and renal complications post PCI across the continuum of procedural estimated risk. PLoS One 2014;9:e90233.